Skip to content
MedsAcross

Medicine

Mucus Relief 600 mg extended-release tablet

Guaifenesin · Oral · Bryant Ranch Prepack
Available on requestPrescription onlyUS FDA

Mucus Relief 600 mg extended-release tablet is a prescription medicine containing Guaifenesin for oral use, marketed by Bryant Ranch Prepack, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

OTHER INFORMATION tamper evident: do not use if seal on the bottle printed…

Key facts

Active ingredient (INN)
Guaifenesin
Brand
Mucus Relief
Strength
600 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
30 tablets, 20 tablets, 60 tablets and 3 more
Marketing authorisation holder
Bryant Ranch Prepack
Manufacturer
Bryant Ranch Prepack
Origin register
US FDA, United States
Storage
OTHER INFORMATION tamper evident: do not use if seal on the bottle printed "SEALED for YOU PROTECTION" is broken or missing. store between 20 to 25°C (68 to 77°F)
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
R05CA03 Guaifenesin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
23 September 2019
Identifiers
RxCUI 636522DailyMed set ID c648e711-e944-4574-83b3-ccce8732384eNDC 71335-2642Application ANDA209215

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
30 tablet, extended release in 1 bottle71335-2642-1Bryant Ranch Prepack2 June 2025
20 tablet, extended release in 1 bottle71335-2642-2Bryant Ranch Prepack2 June 2025
60 tablet, extended release in 1 bottle71335-2642-3Bryant Ranch Prepack2 June 2025
40 tablet, extended release in 1 bottle71335-2642-4Bryant Ranch Prepack2 June 2025
14 tablet, extended release in 1 bottle71335-2642-5Bryant Ranch Prepack2 June 2025
6 tablet, extended release in 1 bottle71335-2642-6Bryant Ranch Prepack2 June 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 12 July 2002Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Guaifenesin is an expectorant. It is available as extended-release tablets for oral use. MedsAcross supplies Guaifenesin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Guaifenesin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Mucus Relief 600 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.